Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphomaBlanca Xicoy, Josep‐María Ribera, Pilar Miralles et al.|Haematologica|2007Cited by 123
Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppressionFederico Pulido, José Ramón Arribas, Ignacio Valero et al.|Antiviral Therapy|2009Cited by 60
HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy eraMaria João Baptista, José‐Tomás Navarro, Olga García et al.|AIDS|2015Cited by 50
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient CharacteristicsJuan Berenguer, Carmen Quereda, Antonio Rivero et al.|Open Forum Infectious Diseases|2016Cited by 42
Clinical experience with integrase inhibitors in HIV-2-infected individuals in SpainSilvia Requena, Carmen Raya, Marta García‐Campello et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 20